Goldman Sachs Group Inc Grifols Sa Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Grifols Sa stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,512,695 shares of GRFS stock, worth $35.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,512,695
Previous 3,025,124 49.17%
Holding current value
$35.3 Million
Previous $19.1 Million 110.26%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$6.28 - $9.38 $9.34 Million - $14 Million
1,487,571 Added 49.17%
4,512,695 $40.1 Million
Q2 2024

Aug 13, 2024
SELL
$6.27 - $7.7 $871,862 - $1.07 Million
-139,053 Reduced 4.39%
3,025,124 $19.1 Million
Q1 2024

May 15, 2024
BUY
$5.47 - $11.38 $12.7 Million - $26.4 Million
2,323,021 Added 276.17%
3,164,177 $21.1 Million
Q4 2023

Feb 13, 2024
SELL
$7.71 - $11.56 $276,110 - $413,986
-35,812 Reduced 4.08%
841,156 $9.72 Million
Q3 2023

May 14, 2024
BUY
$8.91 - $10.91 $319,084 - $390,708
35,812 Added 4.26%
876,968 $8.02 Million
Q3 2023

Nov 14, 2023
SELL
$8.91 - $10.91 $5.21 Million - $6.38 Million
-584,989 Reduced 40.01%
876,968 $8.02 Million
Q2 2023

May 14, 2024
BUY
$7.14 - $9.29 $3.34 Million - $4.34 Million
467,373 Added 46.99%
1,461,957 $13.4 Million
Q2 2023

Aug 14, 2023
BUY
$7.14 - $9.29 $3.34 Million - $4.34 Million
467,373 Added 46.99%
1,461,957 $13.4 Million
Q1 2023

May 14, 2024
BUY
$6.65 - $10.69 $1.92 Million - $3.09 Million
289,187 Added 41.0%
994,584 $7.33 Million
Q1 2023

May 11, 2023
BUY
$6.65 - $10.69 $1.92 Million - $3.09 Million
289,187 Added 41.0%
994,584 $7.33 Million
Q4 2022

May 14, 2024
SELL
$5.96 - $8.53 $8.28 Million - $11.9 Million
-1,389,712 Reduced 66.33%
705,397 $6 Million
Q4 2022

Feb 13, 2023
SELL
$5.96 - $8.53 $8.28 Million - $11.9 Million
-1,389,712 Reduced 66.33%
705,397 $6 Million
Q3 2022

May 14, 2024
SELL
$5.95 - $14.3 $5.68 Million - $13.6 Million
-953,860 Reduced 31.28%
2,095,109 $12.9 Million
Q3 2022

Nov 10, 2022
SELL
$5.95 - $14.3 $5.68 Million - $13.6 Million
-953,860 Reduced 31.28%
2,095,109 $12.9 Million
Q2 2022

May 14, 2024
BUY
$10.6 - $13.28 $23.4 Million - $29.3 Million
2,207,813 Added 262.47%
3,048,969 $36.2 Million
Q2 2022

Aug 15, 2022
BUY
$10.6 - $13.28 $17.8 Million - $22.3 Million
1,675,639 Added 122.01%
3,048,969 $36.2 Million
Q1 2022

May 16, 2022
SELL
$10.37 - $12.73 $5.69 Million - $6.99 Million
-548,786 Reduced 28.55%
1,373,330 $16 Million
Q4 2021

Feb 14, 2022
SELL
$10.21 - $15.27 $11 Million - $16.4 Million
-1,074,253 Reduced 35.85%
1,922,116 $21.6 Million
Q3 2021

Nov 10, 2021
BUY
$14.07 - $17.3 $42.2 Million - $51.8 Million
2,996,369 New
2,996,369 $43.8 Million

Others Institutions Holding GRFS

# of Institutions
164
Shares Held
140M
Call Options Held
288K
Put Options Held
389K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email